fda approves semaglutide for cardiovascular risk reduction Wegovy Reducing Risks FDA approves Novo Nordisk's Wegovy

Bloating or Discomfort Backed-up food and waste in the gastrointestinal tract can lead to bloating, abdominal distension, and discomfort in people experiencing constipation during Ozempic therapy

[] They also aid in transporting essential growth factors and nutrients to RGCs

It is an excellent option for individuals with obesity, Type 2 diabetes, or weight-related health conditions who need extra support to achieve their goals

Are there serious risks or rare complications I should know about

Whilst these medications offer significant benefits when combined with lifestyle changes, questions persist about potential adverse effects, including pancreatitis

Do you need to declare them